Altered SMRT levels disrupt vitamin D3 receptor signalling in prostate cancer cells.
Khanim FL, Gommersall LM, Wood VH, Smith KL, Montalvo L, O'Neill LP, Xu Y, Peehl DM, Stewart PM, Turner BM, Campbell MJ.
Khanim FL, et al. Among authors: turner bm.
Oncogene. 2004 Sep 2;23(40):6712-25. doi: 10.1038/sj.onc.1207772.
Oncogene. 2004.
PMID: 15300237
Free article.